Fasting for 5 Days a Month Could Transform Your Crohn's Disease—Here's What New Research Shows

A new Stanford Medicine study shows that eating just 700-1,100 calories for five days per month significantly improved both symptoms and inflammation markers in people with mild-to-moderate Crohn's disease. About two-thirds of participants who followed this fasting mimicking diet experienced improvement, compared to less than half in the control group who continued their normal eating patterns.

Crohn's disease affects roughly a million Americans, causing inflammation in the digestive tract that leads to diarrhea, cramping, abdominal pain, and weight loss. Until now, doctors have had limited dietary guidance to offer patients beyond steroids—the only approved treatment for mild Crohn's—which come with significant side effects, especially with long-term use.

What Exactly Is a Fasting Mimicking Diet?

The fasting mimicking diet (FMD) isn't about skipping meals entirely. Instead, participants severely restricted calories for five consecutive days each month, eating plant-based meals totaling between 700 and 1,100 calories daily. For the remaining 25 days of the month, they ate their normal diet. This approach differs from traditional fasting because it provides nutrition while triggering the body's fasting-like responses.

The Stanford study enrolled 97 patients across the country, with 65 following the fasting mimicking diet and 32 in the control group eating normally. Researchers tracked not just symptom improvement but also biological markers of inflammation in blood and stool samples.

How Does Fasting Reduce Gut Inflammation?

The research revealed measurable changes in inflammation markers that explain why patients felt better. The most significant finding was a decline in fecal calprotectin—a protein in stool that directly indicates gut inflammation—in the fasting mimicking group compared to controls. Additionally, inflammation-promoting lipid mediators derived from fatty acids decreased, and immune cells produced fewer inflammatory molecules.

"We were very pleasantly surprised that the majority of patients seemed to benefit from this diet," said Dr. Sidhartha Sinha, an assistant professor of gastroenterology and hepatology at Stanford and senior author of the study. "We noticed that even after just one FMD cycle, there were clinical benefits".

The inspiration for studying this diet came from earlier research showing it could reduce C-reactive protein, a common marker of systemic inflammation. Since many Crohn's patients have elevated inflammatory markers, researchers hypothesized the diet might help this population.

Steps to Understanding If This Diet Might Work for You

• Symptom Improvement Timeline: Benefits appeared quickly—some participants experienced clinical improvements after just one five-day fasting cycle, suggesting you don't need to commit to months of dietary changes to see results.
• Side Effect Profile: Some participants reported fatigue and headaches during the fasting periods, but no serious adverse effects were documented, making it a relatively low-risk intervention to discuss with your doctor.
• Mild-to-Moderate Disease Focus: This diet was specifically studied in people with mild-to-moderate Crohn's disease, so effectiveness in severe cases remains unknown and requires medical guidance.
• Biological Marker Tracking: The study measured objective inflammation markers in stool and blood, not just patient-reported symptoms, providing concrete evidence of reduced gut inflammation beyond subjective feelings.

What About the Gut Microbiome?

While the study documented clear improvements in inflammation markers and symptoms, researchers are still investigating whether changes in the gut microbiome—the community of bacteria living in your digestive tract—contribute to the benefits. Dr. Sinha noted that "there's still a lot more to be done to understand the biology behind how this and other diets work in patients with Crohn's disease". Future research may reveal whether the fasting mimicking diet reshapes bacterial populations in ways that reduce inflammation.

Why This Matters for Crohn's Patients

The findings address a critical gap in Crohn's disease management. "What should I eat?" is perhaps the most common question patients with inflammatory bowel disease ask their doctors, yet there have been few large, rigorous studies of dietary interventions. This randomized controlled clinical trial, published in Nature Medicine in January 2026, provides evidence-based guidance that physicians can now confidently share with patients.

The study's strength lies in measuring both clinical outcomes and biological markers. Dietary studies are notoriously difficult because participants' reports of what they eat aren't always accurate, and the placebo effect can't be avoided when people know which diet they're following. However, the researchers found significant declines in objective inflammation markers in biologic samples alongside improvements in reported symptoms, strengthening confidence in the results.

If you have mild-to-moderate Crohn's disease and are interested in exploring dietary approaches, this research suggests a conversation with your gastroenterologist about whether a fasting mimicking diet might be worth trying. The five-day monthly commitment and rapid symptom improvements make it a practical option to consider alongside or potentially instead of long-term steroid use.